乳腺癌笔束扫描质子治疗后放射性急性肺炎与剂量体积参数的相关性及优化目标
该回顾性病例研究分析一例乳腺癌患者笔束扫描质子治疗后出现放射性肺炎的随访CT影像与质子剂量的相关性。直方图分析显示40 Gy(RBE=1.1)处Hounsfield单位明显增加,肺炎区域对应等LET>5.0 keV/μm且质子剂量>40 Gy。将V50Gy和V40Gy作为同侧肺剂量目标纳入计划,可分别将体积从110 cc和267 cc降至0 cc和3 cc,同时保持靶区覆盖和稳健性。
要点
- 乳腺癌PBS质子治疗中同侧肺剂量管理关键,尤其使用两个前野时束流远端高LET。
- 肺炎区域对应等LET>5.0 keV/μm且质子剂量>40 Gy(RBE=1.1)。
- 以V50Gy和V40Gy限制同侧肺体积的优化目标临床可行,可显著降低肺受量。
核心结论
- 乳腺癌PBS质子治疗计划中同时纳入V50Gy和V40Gy限制同侧肺体积的优化目标是临床可行的,应作为减少肺毒性的策略。
研究设计与样本
- 回顾性病例研究,分析一例乳腺癌PBS质子治疗后发生肺炎患者的随访CT影像(症状出现后1周、1.5个月和4.5个月)与质子剂量的相关性。
- 处方剂量为50 Gy加10 Gy推量,RBE=1.1,每日2 Gy分次照射。
主要发现
- 直方图分析显示40 Gy(RBE=1.1)处Hounsfield单位明显增加,提示潜在剂量体积参数。
- 肺炎相关肺体积被等LET>5.0 keV/μm且质子剂量>40 Gy(RBE=1.1)的区域涵盖。
- 采用McNamara模型分析原计划LET依赖的RBE加权剂量,V50Gy和V40Gy分别为110 cc和267 cc。
- 纳入V50Gy和V40Gy优化目标后,体积分别降至0 cc和3 cc,同时保持靶区剂量覆盖和稳健性。
关键数值与推荐
- 处方剂量50 Gy加10 Gy推量,RBE=1.1,每日2 Gy分次。
- 肺炎区域对应等LET>5.0 keV/μm且质子剂量>40 Gy(RBE=1.1)。
- 原计划V50Gy和V40Gy分别为110 cc和267 cc,优化后降至0 cc和3 cc。
临床怎么用
- 乳腺癌PBS质子治疗计划设计时应考虑将V50Gy和V40Gy作为同侧肺的剂量优化目标,以降低放射性肺炎风险。
局限性
- 本文为单例回顾性病例研究,结论需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Proton treatment using pencil-beam scanning (PBS) for patients with breast cancer offers advantages in achieving a conformal dose distribution while also reducing the cardiac dose. However, when employing 2 anterior fields to mitigate the effects of respiratory motion on dose delivery, managing the ipsilateral lung doses becomes critical due to the high linear-energy transfer (LET) at the distal end of the beams. Although the incidence of radiation pneumonitis (RP) after breast radiation therapy is relatively low, it is essential to address the cases that develop RP following proton treatment to minimize lung toxicity. We conducted a retrospective case study analyzing follow-up computed tomography images taken at 1 week, 1.5 months, and 4.5 months after the onset of the patient's pneumonitis symptoms to correlate them with proton doses. The patient's PBS treatment was prescribed at a dose of 50 Gy with an additional 10 Gy boost, using a relative biological effectiveness (RBE) of 1.1, delivered in 2 Gy daily fractions. Our histogram analysis revealed noticeable increases in Hounsfield units at a dose of 40 Gy (RBE = 1.1), underscoring a potential dose-volume parameter that could help minimize the occurrence of RP. Furthermore, the lung volume associated with the RP was encompassed with an iso-LET level greater than 5.0 keV/μm, with a proton dose exceeding 40 Gy (RBE = 1.1). In examining the LET-dependent RBE-weighted dose using the McNamara model in the original treatment plan, we found the volumes receiving more than 50 Gy (V50Gy) and 40 Gy (V40Gy) were 110 cc and 267 cc, respectively. By incorporating dose objectives of V50Gy and V40Gy to limit the ipsilateral lung volume into PBS plans, the volumes were successfully reduced to 0 cc and 3 cc, while maintaining target dose coverage and robustness. Optimizing a breast PBS plan (RBE = 1.1) using objectives that addressed both the V50Gy and V40Gy to minimize lung exposure was shown to be clinically feasible and should be considered as a strategy to reduce lung toxicity when treating breast cancer with PBS proton therapy.
引用
- Park J, Bradley JA, Mendenhall NP, et al. Radiation-Induced Acute Lung Pneumonitis After Pencil-Beam Scanning Proton Treatment for Breast Cancer: Correlation With Dose-Volume Parameters and Optimization Objectives to Reduce Lung Toxicities. Pract Radiat Oncol. 2025. PMID: 40840709. doi:10.1016/j.prro.2025.07.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。